PMID: 8943059Nov 26, 1996Paper

Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation

Proceedings of the National Academy of Sciences of the United States of America
S AnsieauH J Gruss

Abstract

CD30 is a member of the tumor necrosis factor receptor superfamily, which can transduce signals for proliferation, death, or nuclear factor kappa B (NF-kappa B) activation. Investigation of CD30 signaling pathways using a yeast two-hybrid interaction system trapped a cDNA encoding the tumor necrosis factor receptor-associated factor (TRAF)-2 TRAF homology domain. TRAF-1 and TRAF-3 also interacted with CD30, and > 90% of in vitro-translated TRAF-1 or -2, or 50% of TRAF-3, bound to the CD30 cytoplasmic domain. TRAF-1, -2, and -3 bound mostly, but not exclusively, to the carboxyl-terminal 36 residues of CD30. The binding was strongly inhibited by a CD30 oligopeptide centered around a PXQXT (where X is any amino acid) motif shared with CD40 and the Epstein-Barr virus transforming protein LMP1, indicating that this motif in CD30 is an important determinant of TRAF-1, -2 or -3 interaction. At least 15% of TRAF-1, -2, or -3 associated with CD30 when coexpressed in 293 cells. The association was not affected by CD30 cross-linking. However, cross-linking of CD30 activated NF-kappa B. NF-kappa B activation was dependent on the carboxyl-terminal 36 amino acids of CD30 that mediate TRAF association. TRAF-2 has been previously shown to have...Continue Reading

References

Sep 1, 1995·Trends in Biochemical Sciences·E FeinsteinE Varfolomeev
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·J DuysterJ Y Wang
Mar 10, 1995·Science·G ChengD Baltimore
Oct 1, 1995·European Journal of Immunology·P P McDonaldG Pizzolo
Jul 1, 1994·Cell·A T Carpenter
Jul 1, 1994·The Journal of Cell Biology·R A Heller, M Krönke
Jan 1, 1996·Journal of Cellular Biochemistry·C F WareT L VanArsdale
Jan 23, 1999·Oncogene·S J Baker, E P Reddy

❮ Previous
Next ❯

Citations

Aug 6, 1998·European Journal of Immunology·L A GravesteinJ Borst
Oct 6, 2007·Immunologic Research·Gail A Bishop, Ping Xie
Dec 11, 2002·Cellular Immunology·Sang Yun NamEckhard R Podack
Sep 28, 1999·Molecular Immunology·I F DunnE N Tsitsikov
Apr 1, 1997·Immunology Today·H J GrussF Herrmann
Jun 19, 2001·Current Opinion in Immunology·G A Bishop, B S Hostager
Jul 1, 1997·Critical Reviews in Oncology/hematology·H KnechtP Brousset
Jun 6, 2003·Cytokine & Growth Factor Reviews·Fabienne Mackay, Christine Ambrose
Jun 10, 1998·The Journal of Experimental Medicine·K SaoulliT H Watts
Jun 12, 2003·Current Opinion in Hematology·Maciej Tarkowski
Apr 3, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M F PeraD P Cerretti
Mar 18, 2005·Annual Review of Immunology·Tania H Watts
Apr 25, 2000·Annual Review of Medicine·W B Ershler, E T Keller
Dec 18, 2013·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Jonathan S BoomerJonathan M Green
Nov 6, 2012·Clinical & Developmental Immunology·Agnieszka Kempinska-PodhorodeckaPiotr Milkiewicz
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·T L VanArsdaleC F Ware
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·K M IzumiE D Kieff
May 31, 2011·Leukemia & Lymphoma·Yehuda E DeutschJoseph D Rosenblatt
Dec 19, 2006·Transplantation Proceedings·C SpiridonA Nikaein
Dec 2, 2008·Clinical Transplantation·Camelia SpiridonMichael Mack
Sep 13, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D SainiT Mohanakumar
Nov 9, 2007·Clinical Transplantation·Afzal NikaeinMichael Mack
Jan 6, 2010·Clinical Transplantation·Elizabeth M F L DominguesLuís Cristóvão Porto
Jun 12, 2012·MAbs·Niels W C J van de Donk, Eugen Dhimolea
Jan 24, 2015·Experimental & Molecular Medicine·Myung-Soo Kang, Elliott Kieff
Jan 18, 2014·Cytokine & Growth Factor Reviews·Zuoan YiGail A Bishop
Jan 23, 2003·Annals of the New York Academy of Sciences·Eckhard R PodackHiromi Muta
Sep 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas Younes, Marshall E Kadin
Sep 24, 2016·The American Journal of Dermatopathology·Cynthia M MagroSebastien M de Feraudy
Jul 12, 2003·Leukemia & Lymphoma·Anas YounesBharat B Aggarwal
May 29, 1998·Transplantation·O M MartinezS M Krams
Sep 17, 2003·Nature Reviews. Immunology·Michael Croft
Mar 30, 2001·The Journal of Biological Chemistry·J M ZapataJ C Reed
Jul 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Abdo I BerroDevendra K Agrawal
Feb 14, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jun LiuKathryn Sandberg
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hitoshi NishimuraYasunobu Yoshikai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.